MOD-4023

long-acting growth hormone · OPKO Health, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MOD-4023, covering 2019-10-08 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children [Phase 2]